益生菌和免疫治疗对变应性鼻炎患者外周血Treg的联合调节作用
本文关键词: 变应性鼻炎 免疫治疗 酪酸梭菌 双歧杆菌 CD4+CD25+调节T细胞 出处:《山西医科大学》2017年硕士论文 论文类型:学位论文
【摘要】:目的:通过检测参与本实验的变应性鼻炎患者外周血中CD4+CD25+Treg细胞在外周血CD4+Treg细胞中的所占比(%),进一步比较和探讨口服益生菌和特异性免疫治疗在治疗变应性鼻炎中存在的联合作用。方法:1.根据变应性鼻炎的诊断标准、排除标准收集符合要求的变应性鼻炎患者42例(签署知情同意书),随机分成3组:(1)常乐康组(14例):仅服用常乐康治疗,一个疗程,连续服用3个月。(2)免疫治疗(SIT)组(14例):仅进行特异性免疫治疗,治疗3个月。(3)常乐康+免疫治疗(SIT)组(14例):同时口服常乐康和进行特异性免疫治疗。实验标本为治疗前后变应性鼻炎患者的外周血标本。采用流式细胞仪测定外周血中的CD4+CD25+Treg细胞的含量,统计、比较、分析和探讨口服益生菌和特异性免疫治疗在治疗变应性鼻炎中存在的联合作用。结果:1.三组治疗后的CD4+CD25+Treg细胞含量均高于治疗前,差异有统计学意义(P0.05)。2.常乐康+免疫治疗(SIT)组的CD4+CD25+Treg细胞含量明显高于常乐康组,差异有统计学意义(P0.05)。常乐康+免疫治疗(SIT)组的CD4+CD25+Treg细胞含量明显高于免疫治疗组,差异有统计学意义(SIT)组(P0.05)。结论:1.三组治疗后的外周血中CD4+CD25+Treg细胞含量均高于治疗前,表明这三种治疗方案对变应性鼻炎的治疗均是有效的。2.与常乐康组,免疫治疗(SIT)组相比,常乐康+免疫治疗(SIT)组中CD4+CD25+Treg细胞含量增多,表明口服益生菌和特异性免疫治疗在治疗变应性鼻炎中具有联合作用,联合作用优于单个作用。
[Abstract]:Objective: to compare and explore the effect of oral probiotics and specific immunotherapy on allergic rhinitis patients by detecting the percentage of CD4 CD25 Treg cells in peripheral blood CD4 Treg cells. Methods 1. According to the diagnostic criteria of allergic rhinitis, The exclusion criteria collected 42 patients with allergic rhinitis who met the requirements (sign informed consent form and were randomly divided into 3 groups: 1) Changle Kang group (14 cases): only take Changle Kang treatment, a course of treatment, After 3 months of continuous administration, 14 patients in the SIT-treated group were treated with specific immunotherapy only. After 3 months of treatment, 14 patients in the Changlekang immunotherapy group were treated with both oral and specific immunotherapy. The experimental specimens were peripheral blood samples from patients with allergic rhinitis before and after treatment. Flow cytometry was used to determine the results. The content of CD4 CD25 Treg cells in peripheral blood, The combined effects of oral probiotics and specific immunotherapy in the treatment of allergic rhinitis were analyzed and discussed. Results the CD4 CD25 Treg cells in the three groups after treatment were higher than those before treatment. The content of CD4 CD25 Treg cells in the Changlekang immunotherapy group was significantly higher than that in the Changle Kang group, and the difference was statistically significant (P 0.05). The CD4 CD25 Treg cell content in the Changlekang immunotherapy group was significantly higher than that in the immunotherapy group. Conclusion the content of CD4 CD25 Treg cells in peripheral blood of the three groups after treatment is higher than that before treatment, indicating that these three treatments are effective in the treatment of allergic rhinitis. The content of CD4 CD25 Treg cells in Changlekang immunotherapy group was increased, which indicated that oral probiotics and specific immunotherapy had a combined effect in the treatment of allergic rhinitis, and the combined effect was better than that of single action.
【学位授予单位】:山西医科大学
【学位级别】:硕士
【学位授予年份】:2017
【分类号】:R765.21
【参考文献】
相关期刊论文 前10条
1 刘端端;郭宏庆;;生命早期益生菌干预对变应性鼻炎大鼠CD_4~+CD_(25)~+调节性T淋巴细胞及其转录因子Foxp3的影响[J];临床医药文献电子杂志;2015年07期
2 但刚;刘晨霞;吴丽娟;;T淋巴细胞功能及检测方法[J];国际检验医学杂志;2015年03期
3 陈红江;高明华;邹帆;李朝军;周维康;李奇林;;特异益生菌株对变应性鼻炎患者的免疫调节作用[J];第三军医大学学报;2015年02期
4 于阅尽;谭骏;曹云虹;张慧;贾秀华;叶青;;调节性T细胞与变应性鼻炎特异性脱敏治疗效果的关系[J];山东大学耳鼻喉眼学报;2014年05期
5 张仲林;钟玲;袁明勇;唐春梅;凌保东;;Th1/Th2/Th17/Treg细胞因子在变应性鼻炎发病中的免疫机制研究[J];医学综述;2014年16期
6 李烁;洪海裕;李小敏;高进良;高春生;赵家利;刘邦华;;特异性免疫治疗对变应性鼻炎外周血CD4+CD25+T调节细胞的影响及远期疗效的观察[J];中山大学学报(医学科学版);2013年04期
7 熊祖明;袁杰利;;酪酸梭菌的研究与应用进展[J];中国微生态学杂志;2011年12期
8 张永红;王燕;刘慧婷;;酪酸梭菌双歧杆菌二联活菌治疗儿童反复呼吸道感染临床疗效观察[J];中国药物与临床;2011年10期
9 姚君;王立生;师瑞月;王建尧;李迎雪;张茹;莫镜;;双歧杆菌对溃疡性结肠炎小鼠外周血和肠系膜淋巴结CD4~+ CD25~+ Foxp3~+调节T细胞表达的影响[J];中国微生态学杂志;2011年09期
10 Arthur C Ouwehand;Merja Nermes;Maria Carmen Collado;Nina Rautonen;Seppo Salminen;Erika Isolauri;;Specific probiotics alleviate allergic rhinitis during the birch pollen season[J];World Journal of Gastroenterology;2009年26期
相关会议论文 前1条
1 程雷;朱鲁平;张清照;;益生菌对实验性变应性鼻炎的免疫调节作用[A];全国耳鼻咽喉头颈外科中青年学术会议论文汇编[C];2012年
,本文编号:1535760
本文链接:https://www.wllwen.com/yixuelunwen/wuguanyixuelunwen/1535760.html